Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method
Idioma: Inglés
DOI: 10.1016/j.cmi.2024.04.017
Año: 2024
Publicado en: Clinical Microbiology and Infection 30, 8 (2024), 1080-1082
ISSN: 1198-743X

Tipo y forma: Article (PostPrint)
Área (Departamento): Área Microbiología (Dpto. Microb.Ped.Radio.Sal.Pú.)
Área (Departamento): Proy. investigación HQA (Dpto. Microb.Ped.Radio.Sal.Pú.)


Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material.


Exportado de SIDERAL (2025-01-07-14:07:09)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Microbiología



 Record created 2024-07-04, last modified 2025-01-07


Postprint:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)